Concepedia

A. Torbeyns

AT

Statistics

Publications

11

Citations

897

H-Index

11

Active since

1997

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Belgium)

Otsuka (United States)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

A. Torbeyns is an author at Bristol-Myers Squibb (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Publications per year

1997–2019

11

Publications

11

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia

Teresa A. Pigott, William H. Carson, Anutosh Ranjan Saha et al. · The Journal of Clinical Psychiatry · 2003 · 311 citations

, , +17

Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study

P E Keck, Paul J. Orsulak, Andrew J. Cutler et al. · Journal of Affective Disorders · 2008 · 171 citations

, , +8

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine

W. Chrzanowski, Ronald N. Marcus, A. Torbeyns et al. · Psychopharmacology · 2006 · 146 citations

, , +13

Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study

Allan H. Young, Dan A. Oren, Adam Lowy et al. · The British Journal of Psychiatry · 2008 · 107 citations · Full text

, , +12

Short‐duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (<scp>FOUR</scp>ward study)

Mark Sulkowski, S. Flamm, Zeid Kayali et al. · Liver International · 2016 · 34 citations

, , +12

1–5 of 11